Sensitization of Human Cancer Cells to Gemcitabine by the Chk1 Inhibitor MK-8776: Cell Cycle Perturbation and Impact of Administration Schedule in Vitro and in Vivo
Dartmouth Scholarship
Part of the Pharmacology, Toxicology and Environmental Health Commons